These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25311071)

  • 61. Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin.
    Larsen TB; Rasmussen LH; Gorst-Rasmussen A; Skjøth F; Rosenzweig M; Lane DA; Lip GY
    Am J Med; 2014 Apr; 127(4):329-336.e4. PubMed ID: 24361757
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The reply.
    Larsen TB; Rasmussen LH; Gorst-Rasmussen A; Skjøth F; Rosenzweig M; Lane DA; Lip GY
    Am J Med; 2014 Oct; 127(10):e21. PubMed ID: 25311072
    [No Abstract]   [Full Text] [Related]  

  • 63. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
    Hohnloser SH; Oldgren J; Yang S; Wallentin L; Ezekowitz M; Reilly P; Eikelboom J; Brueckmann M; Yusuf S; Connolly SJ
    Circulation; 2012 Feb; 125(5):669-76. PubMed ID: 22215856
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dabigatran in atrial fibrillation: incremental benefit over a time horizon of 5 or 10 years.
    Messori A; Fadda V; Maratea D; Trippoli S
    J Cardiovasc Med (Hagerstown); 2013 Sep; 14(9):683-5. PubMed ID: 23032961
    [No Abstract]   [Full Text] [Related]  

  • 65. Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study.
    Larsen TB; Rasmussen LH; Gorst-Rasmussen A; Skjøth F; Lane DA; Lip GY
    Am J Med; 2014 Dec; 127(12):1172-8.e5. PubMed ID: 25193361
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Myocardial ischemic events in 'real world' patients treated with dabigatran.
    Shah R
    Am J Med; 2014 Oct; 127(10):e19. PubMed ID: 25311071
    [No Abstract]   [Full Text] [Related]  

  • 67. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
    Bauer KA
    Stroke; 2013 Jun; 44(6 Suppl 1):S38-40. PubMed ID: 23709725
    [No Abstract]   [Full Text] [Related]  

  • 68. Is it time to abandon warfarin and embrace oral direct thrombin inhibitors to prevent stroke in patients with atrial fibrillation?
    Rahme RJ; Bernstein R; Batjer HH; Bendok BR
    Neurosurgery; 2011 Feb; 68(2):N16-7. PubMed ID: 21654569
    [No Abstract]   [Full Text] [Related]  

  • 69. Warfarin versus dabigatran: comparing the old with the new.
    Abraham ME; Marcy TR
    Consult Pharm; 2012 Feb; 27(2):121-4. PubMed ID: 22330953
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Management of anticoagulation around pacemaker and defibrillator surgery.
    Birnie DH; Healey JS; Essebag V
    Circulation; 2014 May; 129(20):2062-5. PubMed ID: 24842933
    [No Abstract]   [Full Text] [Related]  

  • 71. Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation.
    Aryal MR; Ukaigwe A; Pandit A; Karmacharya P; Pradhan R; Mainali NR; Pathak R; Jalota L; Bhandari Y; Donato A
    Am J Cardiol; 2014 Aug; 114(4):577-82. PubMed ID: 24998087
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis.
    Shurrab M; Morillo CA; Schulman S; Kansal N; Danon A; Newman D; Lashevsky I; Healey JS; Crystal E
    Can J Cardiol; 2013 Oct; 29(10):1203-10. PubMed ID: 23993352
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S; Ansell J
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Dabigatran in the prevention of stroke in nonvalvular atrial fibrillation: complex clinical situations and real clinical practice].
    Tkacheva ON; Akasheva DU
    Ter Arkh; 2014; 86(4):103-7. PubMed ID: 24864477
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
    Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
    Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.